Transcriptional Induction of NF-kB-Inducing Kinase by E2F4/5 Facilitates Collective Invasion of Glioma Cells.


Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
07 Mar 2023
Historique:
entrez: 22 3 2023
pubmed: 23 3 2023
medline: 23 3 2023
Statut: epublish

Résumé

The prognosis of high-grade gliomas, such as glioblastoma multiforme (GBM), is extremely poor due to the highly invasive nature of these aggressive cancers. Previous work has demonstrated that TNF-weak like factor (TWEAK) induction of the noncanonical NF-κB pathway increases the invasiveness of glioma cells in an NF-κB-inducing kinase (NIK)-dependent manner. While NIK activity is predominantly regulated at the posttranslational level, we show here that NIK (

Identifiants

pubmed: 36945490
doi: 10.21203/rs.3.rs-2622363/v1
pmc: PMC10029079
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS082554
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Nat Rev Cancer. 2021 Sep;21(9):592-604
pubmed: 34239104
Nutrients. 2016 Jun 28;8(7):
pubmed: 27367721
PLoS One. 2013;8(1):e53676
pubmed: 23301098
Oncogenesis. 2016 Jun 06;5(6):e231
pubmed: 27270613
Curr Biol. 2016 Dec 19;26(24):3288-3302
pubmed: 27889261
Curr Opin Genet Dev. 2017 Dec;47:33-40
pubmed: 28881331
Integr Biol (Camb). 2010 Nov;2(11-12):568-74
pubmed: 20886167
Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):775-87
pubmed: 20493977
J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93
pubmed: 17971532
Nat Cell Biol. 2012 Aug;14(8):777-83
pubmed: 22854810
J Biol Chem. 2013 May 17;288(20):14612-14623
pubmed: 23543740
Curr Cancer Drug Targets. 2019;19(2):101-108
pubmed: 29848277
Mol Cancer. 2015 Jan 27;14:9
pubmed: 25622756
Nucleic Acids Res. 2002 Apr 15;30(8):1859-67
pubmed: 11937641
Toxicol Appl Pharmacol. 2016 Sep 1;306:105-12
pubmed: 27417526
Trends Mol Med. 2019 Apr;25(4):341-360
pubmed: 30926358
J Biol Chem. 2011 Jul 29;286(30):26406-17
pubmed: 21653699
Nat Commun. 2022 Aug 11;13(1):4528
pubmed: 35953476
PLoS One. 2018 Oct 25;13(10):e0206253
pubmed: 30359437
Int J Mol Sci. 2020 Nov 11;21(22):
pubmed: 33187137
J Biol Chem. 2003 Sep 19;278(38):36005-12
pubmed: 12840022
J Neurooncol. 2007 Oct;85(1):39-47
pubmed: 17479228
Nature. 2015 Dec 3;528(7580):93-8
pubmed: 26536111
Int J Clin Exp Pathol. 2015 Nov 01;8(11):14824-9
pubmed: 26823811
Blood. 2012 Nov 1;120(18):3756-63
pubmed: 22968463
J Exp Med. 2020 Jan 6;217(1):
pubmed: 31658985
Chem Biol Interact. 2016 May 5;251:26-33
pubmed: 26996543
Oncol Lett. 2018 Apr;15(4):5412-5416
pubmed: 29556293
Oncogene. 2016 Apr 14;35(15):1899-908
pubmed: 26148229
Sensors (Basel). 2018 Sep 27;18(10):
pubmed: 30262739
Stem Cells. 2009 Aug;27(8):1722-33
pubmed: 19544433
Br J Haematol. 2012 Jun;157(6):702-8
pubmed: 22469134
Am J Cancer Res. 2017 May 01;7(5):1164-1176
pubmed: 28560064
Nat Cell Biol. 2020 Jan;22(1):97-107
pubmed: 31907411
Medicine (Baltimore). 2020 Jan;99(5):e18864
pubmed: 32000390
Front Cell Dev Biol. 2022 Sep 16;10:962481
pubmed: 36187469
Semin Immunol. 2014 Jun;26(3):253-66
pubmed: 24958609
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):40-49
pubmed: 30419317
Medchemcomm. 2018 Apr 12;9(6):963-968
pubmed: 30108985
Cancer Sci. 2020 Jan;111(1):200-208
pubmed: 31778288

Auteurs

Kathryn Pflug (K)

Texas A&M Health Science Center.

Dong Lee (D)

Texas A&M Health Science Center.

Kassandra McFadden (K)

Texas A&M Health Science Center.

Linda Herrera (L)

Texas A&M Health Science Center.

Raquel Sitcheran (R)

Texas A&M Health Science Center.

Classifications MeSH